MDxHealth acquires NovioGendix
New share capital amount and new number of shares
MDxHealth SA announced that it succesfully completed the acquisition of all of the shares in NovioGendix Holding B.V.. The completion of the acquisition took place on September 18, 2015.
As part of the consideration that was paid for the shares in NovioGendix, the Company issued 1,086,956 new shares at an issue price of EUR 4.14 representing the average closing price of the Company's shares on Euronext Brussels during a period of 30 days. The Company announces that further to the issuance of the new shares, the Company's share capital was increased from € 35,097,093.09 to € 35,964,157.89, and its number of issued and outstanding shares was increased from 43,998,490 to 45,085,446 ordinary shares.
In addition to the outstanding shares, the total number of existing warrants on the date of this press release amounts to 2,549,413 warrants which would entitle their holders to 2,678,565 shares with voting rights.
Other news from the department business & finance
